Literature DB >> 9699657

K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.

J M Chiang1, Y H Chou, T B Chou.   

Abstract

Colorectal carcinogenesis is widely thought to follow the adenoma-adenocarcinoma sequence. However, there are two morphologically distinct subtypes of colorectal cancer (CRC), polypoid and ulcerative. We conducted a comparative study to clarify whether different combinations of some commonly involved genetic alterations (including mutations in K-ras, p53, DCC, APC, and Rb genes) may exist between polypoid- and ulcerative-type CRCs, the two morphologically distinct types of CRC. By using PCR-based RFLP, single-strand conformational polymorphism, and loss of heterozygosity analysis, we found that K-ras codon 12 mutation was preferentially involved in polypoid tumor (P < 0.0001). There were no other significant correlations with p53 point mutation or loss of heterozygosity in chromosomes 5q, 17p, and 18q and Rb gene, which have been suggested to be involved in the progression of CRC of both morphological types. Therefore, different combinations of molecular genetic alterations may be involved in morphologically distinct types of colorectal carcinogenesis, and the K-ras codon 12 mutations may play an important role in polypoid growth of CRC. These results shed light on the function of K-ras oncogenes involved in colorectal carcinogenesis and may be important in the future design of genetic screening programs, determination of prognosis, and treatment for patients with CRC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699657

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth.

Authors:  E Hidaka; A Yanagisawa; M Seki; T Setoguchi; Y Kato
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  APC and K-ras gene mutation in aberrant crypt foci of human colon.

Authors:  P Yuan; M H Sun; J S Zhang; X Z Zhu; D R Shi
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Authors:  Patrick Chun; Zev A Wainberg
Journal:  Gastrointest Cancer Res       Date:  2009-09

5.  Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma.

Authors:  Ichiro Hirata; Fang-Yu Wang; Mitsuyuki Murano; Takuya Inoue; Ken Toshina; Takashi Nishikawa; Kentaro Maemura
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

6.  Association between oncogenic RAS mutation and radiologic-pathologic findings in patients with primary rectal cancer.

Authors:  Sung Jae Jo; Seung Ho Kim
Journal:  Quant Imaging Med Surg       Date:  2019-02

7.  Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.

Authors:  K Jelonek; A Gdowicz-Klosok; M Pietrowska; M Borkowska; J Korfanty; J Rzeszowska-Wolny; P Widlak
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

8.  Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.

Authors:  J M Chiang; Y H Wu Chou; T C Chen; K F Ng; J L Lin
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

9.  Morphological change of a laterally spreading rectal tumor over a short period.

Authors:  Hideaki Miyamoto; Yasuhiro Oono; Kuang-l Fu; Hiroaki Ikematsu; Satoshi Fujii; Takashi Kojima; Tomonori Yano; Atsushi Ochiai; Yutaka Sasaki; Kazuhiro Kaneko
Journal:  BMC Gastroenterol       Date:  2013-08-19       Impact factor: 3.067

10.  KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.

Authors:  E Birkeland; E Wik; S Mjøs; E A Hoivik; J Trovik; H M J Werner; K Kusonmano; K Petersen; M B Raeder; F Holst; A M Øyan; K-H Kalland; L A Akslen; R Simon; C Krakstad; H B Salvesen
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.